Journal of Clinical Densitometry
Volume 9, Issue 2 , Pages 144-149 , April 2006

New or Worsening Lumbar Spine Vertebral Fractures Increase Lumbar Spine Bone Mineral Density and Falsely Suggest Improved Skeletal Status

  • John H. Krege

      Affiliations

    • Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
    • Corresponding Author InformationAddress correspondence to: John H. Krege, MD, Eli Lilly and Company, Lilly Corporate Center, DC 6134, Indianapolis, IN 46285.
    • ,
  • Paul D. Miller

      Affiliations

    • Department of Medicine, University of Colorado Health Sciences Center and Colorado Center for Bone Research, Denver, CO
    • ,
  • Leon Lenchik

      Affiliations

    • Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC
    • ,
  • Derek A. Misurski

      Affiliations

    • Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN
    • ,
  • Peiqi Chen

      Affiliations

    • Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN

Received 23 August 2005 ,Revised 26 December 2005 ,Accepted 21 February 2006.

References 

  1. Hui SL, Slemenda CW, Johnston CC. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81(6):1804–1809
  2. Ravaud P, Reny JL, Giraudeau B, Porcher R, Dougados M, Roux C. Individual smallest detectable difference in bone mineral density measurements. J Bone Miner Res. 1999;14(8):1449–1456
  3. Orwoll ES, Oviatt SK, Mann T. The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab. 1990;70(4):1202–1207
  4. Reid IR, Evans MC, Ames R, Wattie DJ. The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women. J Clin Endocrinol Metab. 1991;72(6):1372–1374
  5. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434–1441
  6. Ettinger B, Black DM, Mitlak BH, et al. the Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA. 1999;282(7):637–645
  7. Lu Y, Ye K, Mathur AK, Hui S, Fuerst TP, Genant HK. Comparative calibration without a gold standard. Stat Med. 1997;16(16):1889–1905
  8. Lu Y, Mathur AK, Blunt BA, et al. Dual X-ray absorptiometry quality control: comparison of visual examination and process-control charts. J Bone Miner Res. 1996;11(5):626–637
  9. Grigoryan M, Guermazi A, Roemer FW, Delmas PD, Genant HK. Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J. 2003;12(Suppl 2):S104–S112
  10. Genant HK, Jergas M, Palermo L, et al. The Study of Osteoporotic Fractures Research Group Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res. 1996;11(7):984–996
  11. Harris ST, Watts NB, Genant HK, et al. the Vertebral Efficacy With Risedronate Therapy (VERT) Study Group Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA. 1999;282(14):1344–1352
  12. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137–1148
  13. Lenchik L, Kiebzak GM, Blunt BA. What is the role of serial bone mineral density measurements in patient management?. J Clin Densitom. 2002;5(Suppl):S29–S38
  14. Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res. 2002;17(1):1–10
  15. Guermazi A, Mohr A, Grigorian M, Taouli B, Genant HK. Identification of vertebral fractures in osteoporosis. Semin Musculoskelet Radiol. 2002;6(3):241–252
  16. Faulkner KG. Clinical use of bone densitometry. In:  Marcus R,  Feldman D,  Kelsey J editor. Osteoporosis. San Diego, CA: Academic Press; 2001;p. 433–458
  17. Rea JA, Li J, Blake GM, Steiger P, Genant HK, Fogelman I. 2000 Visual assessment of vertebral deformity by X-ray absorptiometry: a highly predictive method to exclude vertebral deformity. Osteoporos Int. 2000;11(8):660–668
  18. Binkley N, Krueger D, Gangnon R, Genant HK, Drezner MK. Lateral vertebral assessment: a valuable technique to detect clinically significant vertebral fractures. Osteoporos Int. 2005;16(12):1513–1518
  19. Vokes TJ, Dixon LB, Favus MJ. Clinical utility of dual-energy vertebral assessment (DVA). Osteoporos Int. 2003;14(11):871–878
  20. Ferrar L, Jiang G, Barrington NA, Eastell R. 2000 Identification of vertebral deformities in women: comparison of radiological assessment and quantitative morphometry using morphometric radiography and morphometric X-ray absorptiometry. J Bone Miner Res. 2000;15(3):575–585
  21. Wu C, Genant H, von Ingersleben G, et-al. 2004 Validation of lateral DXA imaging for assessment of vertebral fractures. 26th Annual Meeting of the American Society of Bone and Mineral Research, Seattle WA, 2004 (Abstract SU381).
  22. Johnell O, Kanis JA, Black DM, et al. Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study. J Bone Miner Res. 2004;19(5):764–772

PII: S1094-6950(06)00032-1

doi: 10.1016/j.jocd.2006.02.001

Journal of Clinical Densitometry
Volume 9, Issue 2 , Pages 144-149 , April 2006

Article Tools

* Image Usage & Resolution